NexgenRxNEGXF 51 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates NEGXF with a GF Score™ of 51/100 and a GF Value™ of $0.27 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 248 Healthcare Providers & Services companies, NexgenRx ranks worse than 69.76% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. NexgenRx's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for NexgenRx's Dividend Payout Ratio or its related term are showing as below:
NEGXF'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.67 Med: 1.5 Max: 2
Current: 0.67
During the past 13 years, the highest Dividend Payout Ratio of NexgenRx was 2.00. The lowest was 0.67. And the median was 1.50.
NEGXF's Dividend Payout Ratio is ranked worse than 69.76% of 248
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs NEGXF: 0.67
During the past 12 months, NexgenRx's average Dividends Per Share Growth Rate was 50.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 14.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of NexgenRx was 14.50% per year. The lowest was 14.50% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
NexgenRx (OTCPK:NEGXF) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
NexgenRx Dividend Payout Ratio Related Terms
NexgenRx Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for NexgenRx's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NEGXF vs VEEV, BTSG, TEM: Dividend Payout Ratio Comparison
For the Health Information Services subindustry, NexgenRx's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NexgenRx Dividend Payout Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NexgenRx's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where NexgenRx's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
NexgenRx's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexgenRx (NEGXF) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on NexgenRx and its competitors. Over the past decade, NexgenRx's Dividend Payout Ratio has ranged from 0.67 to 2.00. According to the industry distribution chart, NexgenRx ranks #173 out of 248 companies in the Healthcare Providers & Services industry, placing it in the top 69.8%.
Is NexgenRx's Dividend Payout Ratio too high?
NexgenRx's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 2.00. Based on the distribution chart, NexgenRx ranks #173 out of 248 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NexgenRx has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NexgenRx's Dividend Payout Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NexgenRx ranks #173 out of 248 companies for Dividend Payout Ratio. This places NexgenRx in the lower half of its industry. The industry median Dividend Payout Ratio is 0.41. Historically, NexgenRx's own Dividend Payout Ratio has ranged from 0.67 to 2.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Healthcare Providers & Services company?
The median Dividend Payout Ratio among Healthcare Providers & Services companies is 0.41, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on NexgenRx and its competitors. For the Healthcare Providers & Services industry, the median Dividend Payout Ratio is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NexgenRx's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexgenRx stock overvalued right now?
Based on GuruFocus' analysis, NexgenRx (NEGXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $0.33 — trading 20.4% above its estimated fair value. The current Dividend Payout Ratio is 0.00. NexgenRx's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For NexgenRx (NEGXF), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NexgenRx (NEGXF) Overvalued in 2026?
Based on GuruFocus' analysis, NexgenRx stock appears to be overvalued.
The current stock price of $0.33 is trading 20.4% above its estimated GF Value™ of $0.27.
GuruFocus considers NexgenRx to be Modestly Overvalued.
Key valuation signals for NEGXF:
Dividend Payout Ratio: 0.00
GF Value™: $0.27 vs. price of $0.33 (20.4% above fair value)
No single metric tells the full story. See the NEGXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
51GF Score
Get the complete analysis for NEGXF
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEGXF has been successfully added to your 
